Literature DB >> 27230995

Postoperative Medical Management of Crohn's Disease: Prevention and Surveillance Strategies.

Miguel Regueiro1, Scott A Strong2, Linda Ferrari3, Alessandro Fichera4.   

Abstract

Entities:  

Keywords:  Crohn's disease; Patient risk stratification; Postoperative medical management; Prevention of postoperative recurrence

Year:  2016        PMID： 27230995     DOI： 10.1007/s11605-016-3172-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  20 in total

Review 1.  Review article: the natural history of postoperative Crohn's disease recurrence.

Authors:  A Buisson; J-B Chevaux; P B Allen; G Bommelaer; L Peyrin-Biroulet
Journal:  Aliment Pharmacol Ther       Date:  2012-02-07       Impact factor: 8.171

2.  Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum.

Authors:  G R D'Haens; K Geboes; M Peeters; F Baert; F Penninckx; P Rutgeerts
Journal:  Gastroenterology       Date:  1998-02       Impact factor: 22.682

Review 3.  Cumulative incidence of second intestinal resection in Crohn's disease: a systematic review and meta-analysis of population-based studies.

Authors:  Alexandra D Frolkis; Debra S Lipton; Kirsten M Fiest; María E Negrón; Jonathan Dykeman; Jennifer deBruyn; Nathalie Jette; Talia Frolkis; Ali Rezaie; Cynthia H Seow; Remo Panaccione; Subrata Ghosh; Gilaad G Kaplan
Journal:  Am J Gastroenterol       Date:  2014-10-21       Impact factor: 10.864

4.  Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.

Authors:  Konstantinos Papamichael; Emmanuel Archavlis; Constantina Lariou; Gerassimos J Mantzaris
Journal:  J Crohns Colitis       Date:  2012-03-15       Impact factor: 9.071

5.  Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial.

Authors:  Koji Yoshida; Ken Fukunaga; Hiroki Ikeuchi; Koji Kamikozuru; Nobuyuki Hida; Yoshio Ohda; Yoko Yokoyama; Masaki Iimuro; Naohisa Takeda; Kyoichi Kato; Risa Kikuyama; Kazuko Nagase; Kazutoshi Hori; Shiro Nakamura; Hiroto Miwa; Takayuki Matsumoto
Journal:  Inflamm Bowel Dis       Date:  2011-11-13       Impact factor: 5.325

6.  Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease.

Authors:  Glen A Doherty; Rebecca A Miksad; Adam S Cheifetz; Alan C Moss
Journal:  Inflamm Bowel Dis       Date:  2011-09-08       Impact factor: 5.325

7.  Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: partial benefit by infliximab--a pilot study.

Authors:  Dario Sorrentino; Giovanni Terrosu; Alberto Paviotti; Marco Geraci; Claudio Avellini; Giorgio Zoli; Walter Fries; Silvio Danese; Pietro Occhipinti; Tiziano Croatto; Dimitra Zarifi
Journal:  Dig Dis Sci       Date:  2012-01-18       Impact factor: 3.199

Review 8.  Management of postoperative Crohn's disease.

Authors:  Siew C Ng; Michael A Kamm
Journal:  Am J Gastroenterol       Date:  2008-03-26       Impact factor: 10.864

9.  Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn's disease after ileocolonic resection: A prospective pilot study.

Authors:  Takayuki Yamamoto; Manabu Shiraki; Takuya Bamba; Satoru Umegae; Koichi Matsumoto
Journal:  United European Gastroenterol J       Date:  2013-10       Impact factor: 4.623

Review 10.  Interactions between the microbiota and the immune system.

Authors:  Lora V Hooper; Dan R Littman; Andrew J Macpherson
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728
View more
  2 in total

1.  Common Chronic Complications Following Inflammatory Bowel Disease Surgery.

Authors:  Scott A Strong
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-04

Review 2.  Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice.

Authors:  Catherine Reenaers; Peter Bossuyt; Pieter Hindryckx; Hilde Vanpoucke; Anneline Cremer; Filip Baert
Journal:  United European Gastroenterol J       Date:  2018-06-20       Impact factor: 4.623
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.